Cargando…
Predictors of Outcome of Non–Muscle-Invasive and Muscle-Invasive Bladder Cancer
Bladder cancer is a major cause of morbidity and mortality. At initial diagnosis, 75% of patients present with non—muscle-invasive disease and 25% of patients have muscle-invasive or metastatic disease.Patients with noninvasive disease suffer from a high rate of recurrence and 10–30% will have disea...
Autores principales: | Youssef, Ramy F., Lotan, Yair |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
TheScientificWorldJOURNAL
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733251/ https://www.ncbi.nlm.nih.gov/pubmed/21336453 http://dx.doi.org/10.1100/tsw.2011.28 |
Ejemplares similares
-
Metabolomics analysis reveals distinct profiles of nonmuscle‐invasive and muscle‐invasive bladder cancer
por: Sahu, Divya, et al.
Publicado: (2017) -
An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer
por: Soria, Francesco, et al.
Publicado: (2018) -
Lymphadenectomy in Management of Invasive Bladder Cancer
por: Youssef, Ramy F., et al.
Publicado: (2011) -
Bladder Preservation for Muscle Invasive Bladder Cancer
por: Mirza, Arafat, et al.
Publicado: (2016) -
Non-muscle invasive bladder cancer risk stratification
por: Isharwal, Sumit, et al.
Publicado: (2015)